Medium risk Medical DevicesClass II

Siemens Atellica CH Urine Albumin Recall

Atellica CH Urine Albumin REF: 11537225, in vitro diagnostic

Updated July 6, 2026

Siemens Atellica CH Urine Albumin test kits may produce falsely low results for urea nitrogen and hemoglobin A1c levels, or experience delayed results due to quality control failures. This can lead to misdiagnosis and incorrect patient care decisions.

Is the Siemens Healthcare Diagnostics, Inc. recalled? Yes. This product was recalled by FDA on July 6, 2026. Details below.

What is recalled

Atellica CH Urine Albumin REF: 11537225, in vitro diagnostic test kits manufactured by Siemens Healthcare Diagnostics, Inc.

Am I affected

You are affected if your laboratory uses Atellica CH Urine Albumin REF: 11537225 test kits on Siemens CI analyzers.

What to do right now

Contact Siemens Healthcare Diagnostics, Inc. immediately to report any affected test kits in your facility and to request a replacement or corrective action. Do not rely on results from this test kit without verification from Siemens.

The hazard

Processing of urine albumin assay on the CI analyzers may lead to the following issues: Falsely depressed Atellica CH Urea Nitrogen (UN_c) results; Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results; Increased rate of reaction cuvette QC failures and Delayed results due to QC failures.

Brands affected

Source
FDA
Category
Medical Devices
Recall ID
fda-Z-2890-2026
Classification
Class II
Recalled
July 6, 2026
Read the official notice

Get free recall alerts

New Medical Devices recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Medical Devices recalls